A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Protein kinases play a pivotal role in cell signaling, and dysregulation of many kinases has been linked to disease development. A large number of kinase inhibitors are therefore currently under investigation in clinical trials, and so far seven inhibitors have been approved as anti-cancer drugs. In...
Hlavní autoři: | Fedorov, O, Marsden, B, Pogacic, V, Rellos, P, Müller, S, Bullock, A, Schwaller, J, Sundström, M, Knapp, S |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2007
|
Podobné jednotky
-
FIKK Kinase, a Ser/Thr Kinase Important to Malaria Parasites, Is Inhibited by Tyrosine Kinase Inhibitors
Autor: Benjamin C. Lin, a další
Vydáno: (2017-10-01) -
Insights for the development of specific kinase inhibitors by targeted structural genomics.
Autor: Fedorov, O, a další
Vydáno: (2007) -
Natural Compounds and Derivatives as Ser/Thr Protein Kinase Modulators and Inhibitors
Autor: Barbara Guerra, a další
Vydáno: (2019-01-01) -
Structural analysis identifies imidazo[1,2-b]pyridazines as PIM kinase inhibitors with in vitro antileukemic activity.
Autor: Pogacic, V, a další
Vydáno: (2007) -
Substrate Specificity of Recombinant Ser/Thr Protein Kinase
Autor: Anna Zorina, a další
Vydáno: (2015-03-01)